Document is current
Any future updates will be listed below
-
Authors
Meyer, Cindy
Garzia, Aitor https://orcid.org/0000-0002-6270-1369
Miller, Michael W.
Huggins, David J.
Myers, Robert W.
Hoffmann, Hans-Heinrich https://orcid.org/0000-0003-0554-0244
Ashbrook, Alison W. https://orcid.org/0000-0003-1114-1426
Jannath, Syeda Y.
Liverton, Nigel
Kargman, Stacia
Zimmerman, Matthew
Nelson, Andrew M.
Sharma, Vijeta
Dolgov, Enriko
Cangialosi, Julianna
Penalva-Lopez, Suyapa
Alvarez, Nadine
Chang, Ching-Wen
Oswal, Neelam
Gonzalez, Irene https://orcid.org/0000-0003-4821-4852
Rasheed, Risha
Goldgirsh, Kira
Davis, Jada A.
Ramos-Espiritu, Lavoisier
Menezes, Miriam-Rose
Larson, Chloe
Nitsche, Julius
Ganichkin, Oleg
Alwaseem, Hanan https://orcid.org/0000-0002-4946-1436
Molina, Henrik
Steinbacher, Stefan
Glickman, J. Fraser https://orcid.org/0000-0002-6706-4039
Perlin, David S. https://orcid.org/0000-0002-1268-5524
Rice, Charles M. https://orcid.org/0000-0003-3087-8079
Meinke, Peter T. https://orcid.org/0000-0002-7548-6215
Tuschl, Thomas https://orcid.org/0000-0002-6483-5678
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 31 October 2024
First Online: 11 December 2024
Competing interests
: The authors declare no competing interests. The Rockefeller University filed patent application PCT/US2024/012695 titled ‘Sulfonamide-1H-pyrrole-2-carboxamide inhibitors of SARS-CoV-2 NSP14 methyltransferase and derivatives thereof’.
